PrescriptionDrugs.org

What to Expect When Starting Prednisolone

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Prednisolone is a corticosteroid used to reduce inflammation and suppress immune activity in a wide range of conditions including asthma, allergic reactions, inflammatory bowel disease, rheumatoid arthritis, and autoimmune diseases. It acts quickly, often within hours of the first dose. Short-term courses (under 2 weeks) have fewer risks; longer courses require careful monitoring and gradual tapering to avoid adrenal suppression.

Week-by-week timeline

Days 1-3

Rapid Anti-Inflammatory Effect

Inflammation, pain, and swelling begin to reduce within hours to days of starting prednisolone. Common early side effects include increased appetite, fluid retention, mild mood elevation or irritability, difficulty sleeping, and elevated blood sugar. Take with food or milk to prevent stomach upset.

Days 4-7

Peak Short-Term Effects

Symptoms of the treated condition should be substantially improved. Side effects including facial puffiness, increased sweating, and mood changes are most noticeable during this period. Blood sugar may be elevated — monitor if diabetic.

Weeks 2-4

Ongoing Benefit and Side Effects

For courses lasting 2-4 weeks, inflammation remains controlled. If on a tapering schedule, dose begins to decrease. Weight gain, fluid retention, and insomnia may continue. Skin may become fragile or prone to bruising.

Month 1+

Long-Term Considerations

Long-term prednisolone use (more than 3 months) requires monitoring for osteoporosis, cataracts, adrenal suppression, elevated blood pressure, and increased infection risk. A calcium and vitamin D supplement is typically recommended. Do not stop abruptly.

When to call your doctor

Contact your healthcare provider if you experience:

  • Signs of serious infection: high fever, chills, severe cough, unusual pain — immune system is suppressed
  • Blood sugar over 250 mg/dL or symptoms of hyperglycemia: extreme thirst, frequent urination, blurred vision
  • Severe mood changes: extreme euphoria, depression, or confusion (steroid psychosis — rare but real)
  • Sudden severe abdominal pain (possible peptic ulcer perforation)
  • Signs of adrenal crisis if abruptly stopped: severe weakness, dizziness, fainting
  • Bone pain or fractures with minimal trauma (long-term use)

Tips for getting started

Always take prednisolone with food or milk to reduce stomach irritation. Never stop prednisolone abruptly after more than 2 weeks of use — the body needs time to resume its own cortisol production. Follow the tapering schedule your doctor provides exactly. Avoid close contact with people who have chickenpox, measles, or other infections during treatment. Limit salt intake to reduce fluid retention. Take calcium and vitamin D if on long-term therapy.

Frequently asked questions

More about Prednisolone

References

  1. [Regulatory] FDA Prescribing Information for Prednisolone https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/009003s039lbl.pdf Accessed 2026-03-01.
  2. [Regulatory] NIH MedlinePlus: Prednisolone https://medlineplus.gov/druginfo/meds/a682924.html Accessed 2026-03-01.
  3. [Clinical] American College of Rheumatology: Glucocorticoid-Induced Osteoporosis Guidelines https://www.rheumatology.org/Practice-Quality/Clinical-Support/Clinical-Practice-Guidelines/Glucocorticoid-Induced-Osteoporosis Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: